logo

Contact information

CV

Academic education

2003 - 2007 PhD-program, Max Planck Institute for Plant Breeding Research, Cologne, Germany
1997 - 2002          MSc in Plant Biotechnology, University of Naples Federico II, Italy

Scientific degrees

2007 PhD, Supervisor: Dr. Zsuzsanna Schwarz Sommer, Max Planck Institute for Plant Breeding Research, Cologne, GermanyHabilitation, Medical Faculty, University of Cologne, Germany

 

Scientific career

2023 - present       Project Leader, CRC-1399, project B09, University of Cologne, Germany
2022 - present Group Leader, Dynamics of mutational processes in cancer, Department of Translational Genomics, University Hospital of Cologne, Germany
2015 - 2022 Research Scientist, Department of Translational Genomics, University Hospital of Cologne, Germany, Division: Computational Cancer Genomics Group
2014 - 2015 Research Scientist, Max Planck Plant Breeding Research, Cologne, Germany

 

Honors/ Awards/ Memberships

               Member of the CRC 1399 Management Board 

Publications

  • LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1

    Microenvironmental bystander cells are essential for the progression of chronic lymphocytic leukemia (CLL). We have discovered previously that LYN kinase promotes the formation of a microenvironmental niche for CLL. Here we provide mechanistic evidence that LYN regulates the polarization of stromal…

  • CaMuS: simultaneous fitting and de novo imputation of cancer mutational signature

    The identification of the mutational processes operating in tumour cells has implications for cancer diagnosis and therapy. These processes leave mutational patterns on the cancer genomes, which are referred to as mutational signatures. Recently, 81 mutational signatures have been inferred using…

  • Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to Immunotherapy

    Pleomorphic dermal sarcoma (PDS) is a rare malignant cutaneous tumor with an unknown cell of origin. Locally defined tumors can be treated by curative excisions, whereas advanced stages of the disease are difficult to treat, using standard regimens. We performed whole-exome sequencing on a cohort…